STOMICS TECH CO., LTD. – Trademark Portfolio
Entity Type: 99
STOMICS TECH CO., LTD. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include STEREO-SEQ. The owner is based in SHENZHEN, GUANGDONG.
ROOM 601, BUILDING B, INTERNATIONAL CONFERENCE CENTER, BGI CENTER
NO. 9 YUNHUA ROAD, BINHAI COMMUNITY, MEISHA STREET, YANTIAN DISTRICT
SHENZHEN, GUANGDONG 518085 , CN
Showing of trademarks Trademarks
Trademark Classifications
STOMICS TECH CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does STOMICS TECH CO., LTD. have?
STOMICS TECH CO., LTD. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does STOMICS TECH CO., LTD. file in?
STOMICS TECH CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 9 (Computers & Electronics). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are STOMICS TECH CO., LTD.'s most well-known trademarks?
STOMICS TECH CO., LTD.'s registered trademark portfolio includes well-known marks such as STEREO-SEQ. These are among 1 currently registered trademark in the portfolio.
What is STOMICS TECH CO., LTD.'s trademark registration success rate?
STOMICS TECH CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.